These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31044609)

  • 21. Newly diagnosed abnormal glucose tolerance determines post-MI prognosis in patients with hospital related hyperglycaemia but without known diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    J Diabetes Complications; 2020 Apr; 34(4):107518. PubMed ID: 31924528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Tanoglidi E; Malmberg K; Näsman P; Rydén L; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2015 Jan; 12(1):23-32. PubMed ID: 25311248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus.
    Henareh L; Agewall S
    Cardiovasc Diabetol; 2012 Aug; 11():93. PubMed ID: 22873202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study.
    Ritsinger V; Jensen J; Ohm D; Omerovic E; Koul S; Fröbert O; Erlinge D; James S; Lagerqvist B; Norhammar A
    Diab Vasc Dis Res; 2019 Nov; 16(6):582-584. PubMed ID: 31476896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive effect of triglyceride‑glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China.
    Zhang Y; Ding X; Hua B; Liu Q; Gao H; Chen H; Zhao XQ; Li W; Li H
    Cardiovasc Diabetol; 2021 Feb; 20(1):43. PubMed ID: 33573649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis.
    Høfsten DE; Løgstrup BB; Møller JE; Pellikka PA; Egstrup K
    JACC Cardiovasc Imaging; 2009 May; 2(5):592-9. PubMed ID: 19442946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.
    Jin JL; Cao YX; Zhang HW; Sun D; Hua Q; Li YF; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu HH; Dong Q; Li JJ
    Diabetes Care; 2019 Jul; 42(7):1312-1318. PubMed ID: 31076417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newly impaired glucose metabolism and prognosis after percutaneous revascularization.
    Jiménez-Navarro MF; Fernández-Pastor J; Garrido-Sánchez L; Molina-Mora MJ; Ortiz-García C; Alonso-Briales JH; Pérez-Cabeza A; Hernández-García JM; de Teresa-Galván E; Tinahones FJ
    Cardiol J; 2015; 22(1):44-51. PubMed ID: 24671899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up.
    Pararajasingam G; Løgstrup BB; Høfsten DE; Christophersen TB; Auscher S; Hangaard J; Egstrup K
    BMC Cardiovasc Disord; 2019 May; 19(1):103. PubMed ID: 31046690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations.
    Tamita K; Katayama M; Takagi T; Yamamuro A; Kaji S; Yoshikawa J; Furukawa Y
    Heart; 2012 Jun; 98(11):848-54. PubMed ID: 22581733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction.
    Wang A; Arver S; Flanagan J; Gyberg V; Näsman P; Ritsinger V; Mellbin LG
    Diab Vasc Dis Res; 2018 Nov; 15(6):511-518. PubMed ID: 30280926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis.
    Laichuthai N; Abdul-Ghani M; Kosiborod M; Parksook WW; Kerr SJ; DeFronzo RA
    Diabetes Care; 2020 Aug; 43(8):1958-1966. PubMed ID: 32669411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly diagnosed diabetes based on an oral glucose tolerance test predicts cardiovascular outcomes in patients with coronary artery disease: An observational study.
    Chen WL; Sheu WH; Li YH; Wang JS; Lee WJ; Liang KW; Lee WL; Lee IT
    Medicine (Baltimore); 2022 Jul; 101(28):e29557. PubMed ID: 35839026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
    Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
    Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
    Kumar A; Patel DR; Wolski KE; Lincoff AM; Kashyap SR; Ruotolo G; McErlean E; Weerakkody G; Riesmeyer JS; Nicholls SJ; Nissen SE; Menon V
    Diab Vasc Dis Res; 2019 Mar; 16(2):171-177. PubMed ID: 31014095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impaired glucose tolerance in patients with acute myocardial infarction].
    Andersen GØ; Eritsland J; Aasheim A; Neuburger J; Knudsen EC; Mangschau A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2264-7. PubMed ID: 16967066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes.
    Cao YX; Zhang HW; Jin JL; Liu HH; Zhang Y; Gao Y; Guo YL; Wu NQ; Hua Q; Li YF; Li XL; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Zhu CG; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):104. PubMed ID: 32631321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.
    Ritsinger V; Brismar K; Mellbin L; Näsman P; Rydén L; Söderberg S; Norhammar A
    Diab Vasc Dis Res; 2018 Sep; 15(5):387-395. PubMed ID: 29992830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.